We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to deliver personalized marketing content and to operate, serve and track ads.
These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.
These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.
Recent Comments
Thank you very much for exposing the current situation at this time of crisis.
Obviously, the best recommendation is not to transfer embryos while the uncertainty of the effects of COVID-19 on pregnant women and foetuses continues.
I also agree that aggressive ovarian stimulation should be avoided, as this could lead to the risk of ovarian hyperstimulation syndrome and possible hospital admission at a time when hospital beds should be made available for all victims of COVID-19.
A key point is whether the virus can be present in the gametes. As stated in this manuscript: "... in the absence of evidence of transmission of the virus within reproductive cells.... But I am not sure if this has been proven already and, as is well known, "the absence of proof does not proof the absence".
Therefore, until we know this, we could not even consider vitrifying oocytes in our patients, with the consequent risk of allowing their ovarian reserve to diminish over the months.
Clearly, we are in a dramatic situation that will paralyse many things, including assisted reproduction treatments, until we are in a safe situation. Obviously, within 9 months, the birth rate will be reduced worldwide, taking into account the number of children born from assisted reproduction treatments.
We must follow all the recommendations that the health authorities send us, in order to flatten the curve and thus be able to recover as soon as possible from this situation.
Dr Elena Labarta
IVI RMA Valencia, Spain